dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
Vaccine protection against acute or chronic viral infection is facilitated by using as an adjuvant or immuno-stimulant, a dsRNA together with an anti-influenza vaccine.
1. A method of enhancing the immune response against a H5N1 avian influenza infection, the method comprising:
(i) co-administration of a seasonal influenza vaccine and a mismatched dsRNA, or
(ii) administration of a composition comprising a seasonal influenza vaccine and a mismatched dsRNA,
wherein the mismatched dsRNA is rI n ·r(C 12 ,U) n , in which n is an integer, rI is polyriboinosinic acid and r(C 12 ,U) is a polyribocytidylic acid sequence containing unpaired uracils,
wherein the mismatched dsRNA acts as an adjuvant or immuno-stimulant, and
wherein the method results in an enhanced immune response against an H5N1 avian influenza infection compared to the administration of seasonal influenza vaccine without the mismatched dsRNA.
2. The method according to claim 1 in which the mismatched dsRNA is additionally complexed with an RNA-stabilizing polymer.
3. The method according to claim 2 in which the stabilizing polymer is lysine or cellulose.
4. The method according to claim 1 , part (i), wherein the seasonal influenza vaccine is administered intranasally and the mismatched dsRNA is administered intranasally.